Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC function

Pulmonary Pharmacology and Therapeutics

Volumn 12, Issue 6, 1999, Pages 377-386

  Gantner, Florian ^a   Schudt, Christian ^a   Wendel, Albrecht ^a   Hatzelmann, Armin ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

APC; Cyclic AMP; Keyhole limpet hemocyanin; LPS; PDE isoenzymes; PDE3 4 synergism; Rolipram; Tetanus toxoid; TNF

Indexed keywords

BUCLADESINE; DEXAMETHASONE; KEYHOLE LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE; MOTAPIZONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PICLAMILAST; PROSTAGLANDIN E2; ROLIPRAM; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA; ZAPRINAST;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033397370     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0220     Document Type: Article

References (37)

1. Van Schooten W. C. A., Strang G., Palathumpat V. Biological properties of dendritic cells: implications to their use in the treatment of cancer. Mol Med Today. 6:1997;254-260.
2. Peters H. J., Gieseler R., Thiele B., Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today. 17:1996;273-278.
3. Austyn J. M. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med. 183:1996;1287-1292.
4. Caux C., Liu Y-J., Banchereau J. Recent advances in study of dendritic cells and follicular dendritic cells. Immunol Today. 16:1995;2-4.
5. Stingl G., Bergstresser P. R. Dendritic cells: a major story unfolds. Immunol Today. 16:1995;330-333.
6. Steinman R. M., Swanson J. The endocytic activity of dendritic cells. J Exp Med. 182:1995;283-288.
7. O'Doherty U., Steinman R. M., Peng M., Cameron P. U., Gezelter S., Kopeloff I., Swiggard W. J., Pope M., Bhardwaj N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med. 178:1993;1067-1076.
8. O'Doherty U., Peng M., Gezelter S., Swiggard W. J., Betjes M., Bhardwaj N., Steinman R. M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 82:1994;487-493.
9. Thomas R., Davis L. S., Lipsky P. E. Isolation and characterization of human peripheral blood dendritic cells. J Immunol. 150:1993;821-834.
10. Lambrecht B. N., Salomon B., Klatzmann D., Pauwels R. A. Dendritic cells are required for the development of chronic eosiniphilic airway inflammation in response to inhaled antigen in sensitzed mice. J Immunol. 160:1998;4090-4097.
11. Houslay M. D., Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. TIBS. 22:1997;217-224.
12. Dent G., Giembycz M. A. Interaction of PDE4 inhibitors with enzymes and cell functions. In: Schudt C, Dent G, Rabe K F eds. Phosphodiesterase Inhibitors London: Academic Press. 1996;115-119.
13. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor- α J Exp Med. 179:1994;1109-1118.
14. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinmann R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med. 180:1994;83-93.
15. Gantner F., Kupferschmidt R., Schudt C., Wendel A., Hatzelmann A. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor- α release by PDE inhibitors. Br J Pharmacol. 121:1997;221-231.
16. Tenor H., Hatzelmann A., Kupferschmidt R., Stanciu L., Djukanovic R., Schudt C., Wendel A., Church M. K., Shute J. S. Cyclic phosphodiesterase activities in human alveolar macrophages. Clin Exp Allergy. 25:1995;625-633.
17. Thompson W. J., Teraski W. L., Epstein P. M., Strada S. J. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucleotide Res. 10:1979;69-92.
18. Bauer A. C., Schwabe U. An improved assay of cyclic 3′, 5′-nucleotide phosphodiesterase with QAE Sephadex A-25. Naunyn-Schmiedebergs Arch Pharmacol. 311:1980;193-198.
19. Gantner F., Tenor H., Gekeler V., Schudt C., Wendel A., Hatzelmann A. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol. 100:1997;527-535.
20. Souness J. E., Maslen C., Webber S., Foster M., Raeburn D., Palfreyman D., Ashton M. J., Karlsson J-A. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Br J Pharmacol. 115:1995;39-46.
21. Zhou L-J., Tedder T. F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 154:1995;3821-3835.
22. Verhasselt V., Buelens C., Willems C., De Groote D., Haeffner-Cavaillon N., Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells. J Immunol. 158:1997;2919-2925.
23. Verhasselt V., Buelens C., Willems C., De Groote D., Haeffner-Cavillon N., Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of constimulatory molecules by human peripheral blood dendritic cells. J Immunol. 158:1997;2919-2925.
24. Essayan D. M., Huang S-K., Kagey-Sobotka A., Lichtenstein L. M. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. J Allergy Clin Immunol. 99:1997;28-37.
25. Epstein P. M., Hachisu R. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Adv Cyclic Nucl Prot Phosphoryl Res. 16:1984;303-324.
26. Robicsek S. A., Blanchard D. K., Djeu J. Y., Krzanowski J. J., Szentivanyi A., Polson J. B. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem Pharmacol. 42:1991;869-877.
27. Essayan D. M., Huang S-K., Undem B. J., Kagey-Sobotka A., Lichtenstein L. M. Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic cucleotide phosphodiesterase inhibitors. J Immunol. 153:1994;3408-3416.
28. +T lymphocytes. Clin Exp Allergy. 25:1995;616-624.
29. +T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol. 118:1996;1945-1958.
30. Ekholm D., Hemmer B., Gao G., Vergelli M., Martin R., Manganiello V. Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein. J Immunol. 159:1997;1520-1529.
31. Gantner F., Küsters S., Wendel A., Hatzelmann A., Schudt C., Tiegs G. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J Pharmacol Exp Ther. 280:1997;53-60.
32. Jackson R. J., Staats H. F., Xu-Amano J., Takahashi I., Kiyono H., Hudson M. E., Gilley R. M., Chatfield S. N., McGhee J. R. Oral vaccine models: multiple delivery systems employing tetanus toxoid. Ann NY Acad Sci. 730:1994;217-234.
33. Comoy E. E., Capron A., Thyphronitis G. In vivo induction of type 1 and type 2 immune responses against protein antigens. Int Immunol. 9:1997;523-531.
34. Essayan D. M., Kagey-Sobotka A., Lichtenstein L. M., Huang S-K. Differential regulation of human antigen-specific Th1 and Th2 lymphocyte responses by isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J Pharmacol Exp Ther. 282:1997;505-512.
35. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 184:1996;747-752.
36. Broide D. H., Lotz M., Coumon A. J., Coburn D. A., Federman E. C., Waserman S. I. Cytokines in symptomatic asthma. J Allergy Clin Immunol. 89:1992;958-967.
37. Poulter L. M., Janossy G., Power C., Screenan S., Burke C. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol Today. 15:1994;258-261.